Literature DB >> 10616350

HIV associated eosinophilic folliculitis--differential diagnosis and management.

S Simpson-Dent1, L A Fearfield, R C Staughton.   

Abstract

Eosinophilic folliculitis (EF) is a chronic, intensely pruritic condition of unknown pathogenesis that causes marked morbidity in those HIV patients whom it affects. There is a wide differential diagnosis of itchy skin conditions in HIV which are amenable to different treatments. It is therefore essential to take a biopsy of each suspected case and examine multiple sections of the biopsy to confirm or refute a diagnosis of EF. Treatment of EF can be difficult but we hope that by suggesting a rational approach to this and considering possible therapeutic options more patients may be helped with this troublesome dermatosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616350      PMCID: PMC1758248          DOI: 10.1136/sti.75.5.291

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  10 in total

1.  Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy.

Authors:  M R Buchness; H W Lim; V A Hatcher; M Sanchez; N A Soter
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

2.  Eosinophilic pustular folliculitis.

Authors:  S Ofuji; A Ogino; T Horio; T Oseko; M Uehara
Journal:  Acta Derm Venereol       Date:  1970       Impact factor: 4.437

3.  Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin.

Authors:  A Blauvelt; R T Plott; K Spooner; B Stearn; R T Davey; M L Turner
Journal:  Arch Dermatol       Date:  1995-03

4.  Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis.

Authors:  T G Berger; V Heon; C King; K Schulze; M A Conant
Journal:  Arch Dermatol       Date:  1995-03

5.  Metronidazole for eosinophilic pustular folliculitis in human immunodeficiency virus type 1-positive patients.

Authors:  K J Smith; H G Skelton; J Yeager; N Ruiz; K F Wagner
Journal:  Arch Dermatol       Date:  1995-09

6.  The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression.

Authors:  S Uthayakumar; R Nandwani; T Drinkwater; A T Nayagam; C R Darley
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

7.  Eosinophilic folliculitis. The histologic spectrum.

Authors:  T H McCalmont; D Altemus; T Maurer; T G Berger
Journal:  Am J Dermatopathol       Date:  1995-10       Impact factor: 1.533

8.  Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis. Results of an open, pilot trial.

Authors:  C C Otley; M R Avram; R A Johnson
Journal:  Arch Dermatol       Date:  1995-09

9.  Eosinophilic folliculitis: a self-limiting illness in patients being treated for haematological malignancy.

Authors:  R H Bull; C A Harland; M E Fallowfield; P S Mortimer
Journal:  Br J Dermatol       Date:  1993-08       Impact factor: 9.302

10.  Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases.

Authors:  F F Soeprono; R A Schinella
Journal:  J Am Acad Dermatol       Date:  1986-06       Impact factor: 11.527

  10 in total
  2 in total

Review 1.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 2.  Inflammatory dermatoses in human immunodeficiency virus.

Authors:  Taru Garg; Sarita Sanke
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.